Oktreotid Teva (Octreotide Acetate)

Octreotide acetate, the active ingredient in Oktreotid Teva, is a somatostatin analog presented as a sterile solution for subcutaneous injection use. It is employed in the management of hormone‑secreting tumors and related endocrine disorders in adults.

GNH USA supplies Oktreotid Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres and oncology centres worldwide.

Oktreotid Teva is a somatostatin analogue that modulates hormonal pathways involved in several endocrine conditions. - Acromegaly: Reduces excess growth hormone secretion and improves clinical symptoms. - Neuroendocrine tumors: Controls hormone‑related flushing, diarrhea and tumor‑associated secretory activity. - Carcinoid syndrome: Alleviates flushing and diarrhoea by inhibiting serotonin‑rich mediators. - Post‑operative post‑pancreate pan     

This